A first‐in‐human study of DS‐1040, an inhibitor of the activated form of thrombin‐activatable fibrinolysis inhibitor, in healthy subjects
ISTH Academy, Jin Zhou, 183333
Phase 1 dose‐escalating study to evaluate the safety, pharmacokinetics, and pharmacodynamics of a recombinant factor Xa variant (FXa)
ISTH Academy, Dana Parsons‐Rich, 183334
Thrombotic and bleeding outcomes following perioperative interruption of direct oral anticoagulants in patients with venous thromboembolic disease
ISTH Academy, Marc Carrier, 183335
Shear‐sensitive nanocapsule drug release for site‐specific inhibition of occlusive thrombus formation
ISTH Academy, Karlheinz Peter, 183336
Long‐term treatment of cancer‐associated thrombosis: the choice of the optimal anticoagulant
ISTH Academy, Ismail Elalamy, 183337
Incomplete reversibility of platelet inhibition following prolonged exposure to ticagrelor
ISTH Academy, Andrew Frelinger, 183338
Towards a tailored diagnostic standard for future diagnostic studies in pulmonary embolism: communication from the SSC of the ISTH
ISTH Academy, Frederikus Klok, 183339
Stay Coagulated and Join the ISTH Today
ISTH Academy, Session Speakers, 183340
Once versus twice daily aspirin after coronary bypass surgery: a randomized trial
ISTH Academy, Jeremy S. Paikin, 183341
Clumping factor A, von Willebrand factor‐binding protein and von Willebrand factor anchor Staphylococcus aureus to the vessel wall
ISTH Academy, Thomas Vanassche, 183342
D‐dimer at venous thrombosis diagnosis is associated with risk of recurrence
ISTH Academy, Esben Bjøri, 183343
Genetics, diagnosis and clinical features of congenital hypodysfibrinogenemia: a systematic literature review and report of a novel mutation
ISTH Academy, Alessandro Casini, 183344
What the neighbors say
ISTH Academy, Session Speakers, 183345
Recombinant fibrinogen reveals the differential roles of α‐ and γ‐chain cross‐linking and molecular heterogeneity in fibrin clot strain‐stiffening
ISTH Academy, Gijsje H. Koenderink, 183346
Comparing thrombin generation in patients with hemophilia A and patients on vitamin K antagonists
ISTH Academy, Roger Schutgens, 183347
Effects of alloantibodies to human leukocyte antigen on endothelial expression and serum levels of thrombomodulin
ISTH Academy, Sacha A. De Serres, 183348
Targeting of C‐type lectin‐like receptor 2 or P2Y12 for the prevention of platelet activation by immunotherapeutic CpG oligodeoxynucleotides
ISTH Academy, Cecile Oury, 183349
Ibrutinib‐associated bleeding: pathogenesis, management and risk reduction strategies
ISTH Academy, Joseph J. Shatzel, 183350
Long‐term outcomes of cancer‐related isolated distal deep vein thrombosis: the OPTIMEV study
ISTH Academy, jean-philippe galanaud, 183351
New functional assays to selectively quantify the activated protein C‐ and tissue factor pathway inhibitor‐cofactor activities of protein S in plasma
ISTH Academy, Tilman Hackeng, 183352
Personalized thromboprophylaxis using a risk score for the management of pregnancies with high risk of thrombosis: a prospective clinical study
ISTH Academy, Yesim Dargaud, 183353
The platelet‐activating receptor C‐type lectin receptor‐2 plays an essential role in liver regeneration after partial hepatectomy in mice
ISTH Academy, Hiroshi Kono, 183354
Disruption of protein complexes containing protein phosphatase 2B and Munc18c reduces the secretion of von Willebrand factor from endothelial cells
ISTH Academy, K. Vinod Vijayan, 183355
Issue Information
ISTH Academy, Session Speakers, 183356
Reproducibility
ISTH Academy, Session Speakers, 183357
Development of Shiny app tools to simplify and standardize the analysis of hemostasis assay data: communication from the SSC of the ISTH
ISTH Academy, Colin Longstaff, 183358
Angiogenesis
ISTH Academy, Juan Melero-Martin, Anna Randi Koralia Paschalaki, 175079
Angiogenesis
ISTH Academy, Juan Melero-Martin, Anna Randi Koralia Paschalaki, 175080
Corrigendum
ISTH Academy, Session Speakers, 183296
Safety, efficacy and pharmacokinetics of rVIII‐SingleChain in children with severe hemophilia A: results of a multicenter clinical trial
ISTH Academy, Ingrid Pabinger-Fasching, 183297
Venous thromboembolism following L‐asparaginase treatment for lymphoid malignancies in Korea
ISTH Academy, Soo-Mee Bang, 183298
Corrigendum
ISTH Academy, Session Speakers, 183299
Expression and characterization of a codon‐optimized blood coagulation factor VIII
ISTH Academy, Andrey Sarafanov, 183300
Dysregulation of PLDN (pallidin) is a mechanism for platelet dense granule deficiency in RUNX1 haplodeficiency
ISTH Academy, A Rao, 183301
Microangiopathic hemolytic anemia due to ADAMTS‐13 loss in idiopathic systemic capillary leak syndrome: reply
ISTH Academy, Jorge DiPaola, 183302
A new antithrombotic strategy: inhibition of the C‐terminal active site of protein disulfide isomerase
ISTH Academy, David W. Essex, 183303
Thrombin contributes to protective immunity in pneumonia‐derived sepsis via fibrin polymerization and platelet–neutrophil interactions
ISTH Academy, Theodora Claushuis, 183304
Lipid levels and risk of recurrent venous thrombosis: results from the MEGA follow‐up study
ISTH Academy, Suzanne Cannegieter, 183307
Fibrinolysis inhibitors in plaque stability: a morphological association of PAI‐1 and TAFI in advanced carotid plaque
ISTH Academy, Ann-Cathrine Jonsson-Rylander, 183309
Targeting coagulation factor receptors – protease‐activated receptors in idiopathic pulmonary fibrosis
ISTH Academy, Cong Lin, 183310
Maresin 1 induces a novel pro‐resolving phenotype in human platelets
ISTH Academy, Richard P. Phipps, 183312
Recombinant soluble apyrase APT102 inhibits thrombosis and intimal hyperplasia in vein grafts without adversely affecting hemostasis or re‐endothelialization
ISTH Academy, William Fay, 183314
The original and simplified Wells rules and age‐adjusted D‐dimer testing to rule out pulmonary embolism: an individual patient data meta‐analysis
ISTH Academy, Nick Van Es, 183315
Net clinical benefit of hospitalization versus outpatient management of patients with acute pulmonary embolism
ISTH Academy, Pierre-Marie Roy, 183316
Clinical and biochemical characterization of the prothrombin Belgrade mutation in a large Serbian pedigree: new insights into the antithrombin resistance mechanism
ISTH Academy, Djordjevic Valentina, 183318
Infections in non‐splenectomized persistent or chronic primary immune thrombocytopenia adults: risk factors and vaccination effect
ISTH Academy, Guillaume Moulis, 183319
Inflammatory bowel disease and venous thromboembolism during pregnancy and the postpartum period
ISTH Academy, Anette Tarp Hansen, 183320
Reproducibility of clinical events adjudications in a trial of venous thromboembolism prevention
ISTH Academy, Philippe Girard, 183323
Filaggrin loss‐of‐function mutations as risk factors for ischemic stroke in the general population
ISTH Academy, Marianne Benn, 183324
Microangiopathic hemolytic anemia due to ADAMTS‐13 loss in idiopathic systemic capillary leak syndrome: comment
ISTH Academy, jecko thachil, 183326
A randomized controlled trial of fresh frozen plasma for coagulopathy in Russell's viper (Daboia russelii) envenoming
ISTH Academy, Geoffrey K Isbister, 183327
Safety, efficacy and pharmacokinetics of rVIII‐SingleChain in children with severe hemophilia A: results of a multicenter clinical trial
ISTH Academy, Ingrid Pabinger-Fasching, 183329
Venous thromboembolism following L‐asparaginase treatment for lymphoid malignancies in Korea
ISTH Academy, Soo-Mee Bang, 183330
Expression and characterization of a codon‐optimized blood coagulation factor VIII
ISTH Academy, Andrey Sarafanov, 183332
Dysregulation of PLDN (pallidin) is a mechanism for platelet dense granule deficiency in RUNX1 haplodeficiency
ISTH Academy, A Rao, 183269
Microangiopathic hemolytic anemia due to ADAMTS‐13 loss in idiopathic systemic capillary leak syndrome: reply
ISTH Academy, Jorge DiPaola, 183270
A new antithrombotic strategy: inhibition of the C‐terminal active site of protein disulfide isomerase
ISTH Academy, David W. Essex, 183271
Thrombin contributes to protective immunity in pneumonia‐derived sepsis via fibrin polymerization and platelet–neutrophil interactions
ISTH Academy, Theodora Claushuis, 183272
Hematology journals do not sufficiently adhere to reporting guidelines: a systematic review
ISTH Academy, Cole Wayant, 183273
Issue Information
ISTH Academy, Session Speakers, 183274
Lipid levels and risk of recurrent venous thrombosis: results from the MEGA follow‐up study
ISTH Academy, Suzanne Cannegieter, 183275
What the neighbors say
ISTH Academy, Session Speakers, 183276
Fibrinolysis inhibitors in plaque stability: a morphological association of PAI‐1 and TAFI in advanced carotid plaque
ISTH Academy, Ann-Cathrine Jonsson-Rylander, 183277
Targeting coagulation factor receptors – protease‐activated receptors in idiopathic pulmonary fibrosis
ISTH Academy, Cong Lin, 183278
Stay Coagulated and Join the ISTH Today
ISTH Academy, Session Speakers, 183279
Maresin 1 induces a novel pro‐resolving phenotype in human platelets
ISTH Academy, Richard P. Phipps, 183280
The effect of correcting VerifyNow P2Y12 assay results for hematocrit in patients undergoing percutaneous coronary interventions
ISTH Academy, P.W.A. Janssen, 183281
Recombinant soluble apyrase APT102 inhibits thrombosis and intimal hyperplasia in vein grafts without adversely affecting hemostasis or re‐endothelialization
ISTH Academy, William Fay, 183282
The original and simplified Wells rules and age‐adjusted D‐dimer testing to rule out pulmonary embolism: an individual patient data meta‐analysis
ISTH Academy, Nick Van Es, 183283
Net clinical benefit of hospitalization versus outpatient management of patients with acute pulmonary embolism
ISTH Academy, Pierre-Marie Roy, 183284
Integrated analysis of genetic variation and gene expression reveals novel variant for increased warfarin dose requirement in African Americans
ISTH Academy, Minoli A. Perera, 183285
Clinical and biochemical characterization of the prothrombin Belgrade mutation in a large Serbian pedigree: new insights into the antithrombin resistance mechanism
ISTH Academy, Djordjevic Valentina, 183286
Infections in non‐splenectomized persistent or chronic primary immune thrombocytopenia adults: risk factors and vaccination effect
ISTH Academy, Guillaume Moulis, 183287
Inflammatory bowel disease and venous thromboembolism during pregnancy and the postpartum period
ISTH Academy, Anette Tarp Hansen, 183288
Novel antiplatelet role for a protein disulfide isomerase‐targeted peptide: evidence of covalent binding to the C‐terminal CGHC redox motif
ISTH Academy, Antonio M. Paes, 183289
Boycott
ISTH Academy, Session Speakers, 183290
Reproducibility of clinical events adjudications in a trial of venous thromboembolism prevention
ISTH Academy, Philippe Girard, 183291
Filaggrin loss‐of‐function mutations as risk factors for ischemic stroke in the general population
ISTH Academy, Marianne Benn, 183292
Modulating immunogenicity of factor IX by fusion to an immunoglobulin Fc domain: a study using a hemophilia B mouse model
ISTH Academy, Zuben E. Sauna, 183293
Microangiopathic hemolytic anemia due to ADAMTS‐13 loss in idiopathic systemic capillary leak syndrome: comment
ISTH Academy, jecko thachil, 183294
A randomized controlled trial of fresh frozen plasma for coagulopathy in Russell's viper (Daboia russelii) envenoming
ISTH Academy, Geoffrey K Isbister, 183295
Fibrinolysis
ISTH Academy, Douglas Vaughan, Robert Medcalf & Paul Kim, 170316
Dabigatran enhances platelet reactivity and platelet thrombin receptor expression in patients with atrial fibrillation
ISTH Academy, Amin Polzin, 170320
Safety and efficacy of BAY 94‐9027, a prolonged‐half‐life factor VIII
ISTH Academy, Mark Reding, 170321
C‐type lectin‐like receptor 2 promotes hematogenous tumor metastasis and prothrombotic state in tumor‐bearing mice
ISTH Academy, Katsue Suzuki-Inoue, 170322
Increased thrombin generation in a mouse model of cancer cachexia is partially interleukin‐6 dependent
ISTH Academy, Caroline Reddel, 170323
Dosing algorithms for vitamin K antagonists across VKORC1 and CYP2C9 genotypes
ISTH Academy, Anke‐Hilse Maitland‐van der Zee, 170324
Hierarchical organization of the hemostatic response to penetrating injuries in the mouse macrovasculature
ISTH Academy, Lawrence Brass, 170325
Age‐stratified outcome of a genotype‐guided dosing algorithm for acenocoumarol and phenprocoumon
ISTH Academy, Anke‐Hilse Maitland‐van der Zee, 170326
Issue Information
ISTH Academy, Session Speakers, 170327
Eltrombopag, a thrombopoietin mimetic, crosses the blood–brain barrier and impairs iron‐dependent hippocampal neuron dendrite development
ISTH Academy, aziz kural, 170328
Eight days a week
ISTH Academy, Session Speakers, 170329
Predictors of active cancer thromboembolic outcomes: validation of the Khorana score among patients with lung cancer: reply
ISTH Academy, Anna Králiková, 170336
The effect of amiodarone on warfarin anticoagulation: a register‐based nationwide cohort study involving the Swedish population
ISTH Academy, Sabine Van Ceulebroeck, 170337
Conformational quiescence of ADAMTS‐13 prevents proteolytic promiscuity: comment
ISTH Academy, ESPID MEMBER, 170338
Clustering of glycoprotein VI (GPVI) dimers upon adhesion to collagen as a mechanism to regulate GPVI signaling in platelets
ISTH Academy, Stephanie Jung, 170339
What the Neighbors Say
ISTH Academy, Session Speakers, 170340
Predictors of active cancer thromboembolic outcomes: validation of the Khorana score among patients with lung cancer: comment
ISTH Academy, Simon Noble, 170341
Inactivation of human coagulation factor X by a protease of the pathogen Capnocytophaga canimorsus
ISTH Academy, Vinay Baddoley, 170342
Monitoring of treatment with vitamin K antagonists: recombinant thromboplastins are more sensitive to factor VII than tissue‐extract thromboplastins
ISTH Academy, M.J.H.A. Kruip, 170343